by Ty Davison | Oct 9, 2016 | News & Commentary
We’ve not yet tested it on every type of cancer, but it’s more successful than chemo and it’s much more easily tolerated by the patient. In a trial of more than 350 patients, published in the New England Journal of Medicine, 36% treated with the immunotherapy...
